Results 171 to 180 of about 4,094,904 (310)

Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley   +1 more source

Pericytes as key mediators of microenvironmental signaling crosstalk: implications in vascular diseases and cancer. [PDF]

Front Cell Dev Biol
Guo Q, Yao Y, Ding Y, Chen L, Zhang Q, Zhang H, Xue J.   +6 more
europepmc   +1 more source

OBLITERATIVE VASCULAR DISEASES, OBLITERATIVE ENDARTERITIS, AND MODERN TREATMENT METHODS

The latest achievements and innovative approaches in the field of medicine have significantly expanded the possibilities for effective treatment of these diseases.
Suyunov Og‘abek Oybek o'g’li
core  

Dysregulated Cholesterol Metabolism, Chronic Inflammation, and Disability in Severe Progressive Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Dysregulated lipid metabolism, which can affect remyelination and neural repair, has not been extensively investigated in progressive multiple sclerosis (PMS). The goal was to examine whether dysregulated cholesterol metabolism was associated with disability in PMS. Methods The study sample comprised 53 Severe PMS patients (Expanded
Taylor R. Wicks, Mujeeb Shittu, Anna Wolska, Diala Ghazal, Bianca Weinstock‐Guttman, Alexander Burnham, Alan T. Remaley, Robert Zivadinov, Murali Ramanathan   +8 more
wiley   +1 more source

ERS Congress 2025: highlights from the Pulmonary Vascular Diseases Assembly. [PDF]

ERJ Open Res
Budhram B, Genecand L, Zeder K, Baccelli A, Bokan A, Cullivan S, Park DH, Foris V, Grynblat J, Jutant EM, Maloir Q, Raza A, Riou M, Robert F, Tenes A, Valentin S, Bogaard HJ, Sitbon O, Boucly A.   +18 more
europepmc   +1 more source

Vertigo, nausea, tinnitus and hearing loss in cardio-vascular diseases /

, 1986
Proceedings of the XIII scientific meeting of the Neurootological and Equilibriometric Society: Vertigo in cardio-vascular diseases, Bad Kissingen, 21-23 March ...
Neurootological and Equilibriometric Society, Kirtane, Milind V.,, Claussen, Claus(viaf)32844704, Scientific meeting of the neurootological and equilibriometric society13th21-23 March 1986Bad Kissingen   +3 more
core  

Dynamic Changes in Serum Glial Fibrillary Acidic Protein Levels Predicts Early Neurological Deterioration After Intravenous Thrombolysis in Minor Stroke

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Minor strokes may be associated with early neurological deterioration (END) and disabilities. The objective was to investigate the role of serum glial fibrillary acidic protein (GFAP) levels in predicting END. Methods Data originated from a multicenter cohort study conducted prospectively.
Jie Zhou, Yang Qu, Reziya Abuduxukuer, Peng Zhang, Ting Wang, Jian‐Hua Gao, De‐Wang Pan, Zhi‐Mei Yuan, Chun‐Ying Li, Li‐Ping Chen, Jin‐Hua Chen, Ji‐Liang Gu, An‐Ying Wang, Li‐Gang Jiang, Liang Liu, Yong‐Fei Jiang, Chun‐Fei Wang, Yan Jia, Hong Xin, Chun‐Li Jiang, Ying‐Bin Qi, Xue‐Feng Hu, Song Li, Hang Jin, Zhen‐Ni Guo, Yi Yang, on behalf of the Biomarkers of Brain Injury Investigator Study Group, Lijuan Wang, Ting Wang, Jianhua Gao, Dewang Pan, Zhimei Yuan, Chunying Li, Liping Chen, Jinhua Chen, Jiliang Gu, Anying Wang, Ligang Jiang, Liang Liu, Yongfei Jiang, Chunfei Wang, Yan Jia, Hong Xin, Chunli Jiang, Yingbin Qi, Xuefeng Hu   +45 more
wiley   +1 more source

COVID-19, Vascular Diseases, and Vascular Services

Clinics
Pedro Puech-Leão, Luiz Antonio Machado César, Nelson De Luccia   +2 more
doaj   +1 more source

Dietary Habits and Lifestyle Factors Associated with Vascular Diseases: A Case-Control Study. [PDF]

Healthcare (Basel)
Zekey FS, Sahin S, Er ZC, Uyar Zekey K, Turksoy VA.   +4 more
europepmc   +1 more source

Artificial Intelligence in Systemic Sclerosis: Clinical Applications, Challenges, and Future Directions

Arthritis Care &Research, EarlyView.
Systemic sclerosis (SSc) is a rare autoimmune disease defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Despite advances in care, major complications such as interstitial lung disease (ILD) and myocardial involvement remain the leading causes of morbidity and mortality.
Cristiana Sieiro Santos, José Miguel Sequí‐Sabater, Diego Benavent   +2 more
wiley   +1 more source